Misdiagnosis Common in Parkinsonian Disorders - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Misdiagnosis Common in Parkinsonian Disorders

Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.

  • By

  • Andrea Surnit

  • June 8, 2026

  • 4 min

Share

Objective:

To investigate the rates of clinical misdiagnosis in Parkinsonian disorders and the factors influencing diagnostic accuracy.

Key Findings:
  • Misdiagnosis rates ranged from approximately 10% to 20% across Parkinsonian disorders.
  • Clinical diagnoses of Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies corresponded with underlying Lewy body pathology in 92% of cases.
  • Donors with dementia-associated parkinsonism were nearly twice as likely to have Lewy body pathology compared to those with Parkinson's disease without dementia.
  • Autopsy findings in patients diagnosed with corticobasal syndrome frequently revealed other pathologies such as progressive supranuclear palsy.
  • 40% of patients with Lewy body disease had coexisting Alzheimer's disease pathology.
Interpretation:

Clinical features alone do not fully capture the biological heterogeneity of Parkinsonian disorders, indicating the need for improved diagnostic approaches.

Limitations:
  • Potential referral and sampling bias due to reliance on brain bank cohorts.
  • Variability in pathologic assessment across centers and time periods.
  • Incomplete documentation of co-pathologies.
  • Limited representation of non-European ancestry groups.
Conclusion:

The study emphasizes the importance of integrating genetic and pathologic data to enhance diagnostic accuracy in Parkinsonian disorders.

Original Source(s)

Misdiagnosis Common in Parkinsonian Disorders

  • by Andrea Surnit

  • June 8, 2026

Related Content

High-Dose Vitamin C Could Pose Risk in Severe Burns

“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.